雄岸科技(1647.HK)大漲16.44% 美眾議院司法委員會通過聯邦大麻合法化法
格隆匯11月22日丨港股大麻概念股上漲,其中,雄岸科技(1647.HK)大漲16.44%,報0.85港元,已連漲3日股價創6月以來新高,最新總市值8.77億港元。
另一隻大麻概念股美瑞健康國際(2327.HK)漲6.74%。
美國民主黨控制的眾議院司法委員會週三投票支持一項在聯邦層面上使大麻合法化的法案,該法案以24票對10票獲得了通過。美股大麻股已連漲三日。
雄岸科技曾在9月份發公告稱擬在美成立合營公司發展工業大麻業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.